Alder BioPharmaceuticals, Inc. News Headlines

ALDR 
$13
*  
0.68
5.52%
Get ALDR Alerts
*Delayed - data as of Sep. 18, 2014 12:56 ET  -  Find a broker to begin trading ALDR now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ALDR Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Alder Biopharmaceuticals (ALDR) in Focus: Stock Up 5.2% - Tale of the Tape
9/18/2014 8:44:00 AM - Zacks.com

Bristol-Myers Returns Clazakizumab Rights, Alder Sinks - Analyst Blog
9/3/2014 11:02:00 AM - Zacks.com

Alder Biopharmaceuticals Slumps: ALDR Tanks 13.2% in Session - Tale of the Tape
9/3/2014 8:51:00 AM - Zacks.com

Sector Update: Health Care Stocks Mixed Just Before Bell; Alder Biopharmaceuticals Sinks After Bayer Drops Arthritis Drug Candidate
9/2/2014 3:59:44 PM - MT Newswires

Sector Update: Health Care
9/2/2014 3:58:16 PM - MT Newswires

Alder Regains Rights To Anti-Inflammation Drug Clazakizumab - Quick Facts
9/2/2014 7:31:00 AM - RTT News

Over half of 2014 IPOs now trade below their opening price
5/8/2014 7:58:00 PM - Renaissance Capital

Alder BioPharmaceuticals prices upsized IPO at $10, well below the range
5/8/2014 8:33:11 AM - Renaissance Capital

Will Alder Biopharmaceuticals IPO Cure Investor Headaches?
5/8/2014 7:39:00 AM - Seeking Alpha

IPO Preview: Alder Biopharmaceuticals
5/7/2014 5:55:00 PM - Seeking Alpha

9 U.S. IPOs Planned For The Week Of May 5
5/6/2014 9:23:00 AM - Seeking Alpha

9 US IPOs planned for the week of May 5
5/5/2014 8:00:04 AM - Renaissance Capital

U.S. IPO Recap: Ares Launches $400 Million IPO
4/29/2014 8:46:00 AM - Seeking Alpha

Antibody biotech Alder BioPharmaceuticals sets terms for $100 million IPO
4/25/2014 11:38:29 AM - Renaissance Capital

U.S. IPO Recap: Year's Largest Biotech IPO Versartis Jumps 49% Amid Tech-Biotech Frenzy
3/24/2014 3:07:00 PM - Seeking Alpha